← Evidence map

ArticleNature cancer2025

A sphingolipid-derived paclitaxel nanovesicle for improved cancer therapy.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40908331